TrialClinical and translational science2025

High-Frequency, At-Home Monitoring of Drug Safety and Tolerability in Clinical Trials: Results From Studies of Fluvoxamine for COVID-19 Treatment.

Eric J Lenze et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.